Comorbidities, multimorbidity and COVID-19
The influence of comorbidities on COVID-19 outcomes has been recognized since the
earliest days of the pandemic. But establishing causality and determining underlying …
earliest days of the pandemic. But establishing causality and determining underlying …
Diabetes and multiple long-term conditions: A review of our current global health challenge
Use of effective treatments and management programs is leading to longer survival of
people with diabetes. This, in combination with obesity, is thus contributing to a rise in …
people with diabetes. This, in combination with obesity, is thus contributing to a rise in …
[HTML][HTML] Comprehensive review of COVID-19: epidemiology, pathogenesis, advancement in diagnostic and detection techniques, and post-pandemic treatment …
YS Chung, CY Lam, PH Tan, HF Tsang… - International Journal of …, 2024 - mdpi.com
At present, COVID-19 remains a public health concern due to the ongoing evolution of
SARS-CoV-2 and its prevalence in particular countries. This paper provides an updated …
SARS-CoV-2 and its prevalence in particular countries. This paper provides an updated …
Ethnic disparities in COVID-19 outcomes: a multinational cohort study of 20 million individuals from England and Canada
Background Heterogeneous studies have demonstrated ethnic inequalities in the risk of
SARS-CoV-2 infection and adverse COVID-19 outcomes. This study evaluates the …
SARS-CoV-2 infection and adverse COVID-19 outcomes. This study evaluates the …
Expert consensus: main risk factors for poor prognosis in COVID-19 and the implications for targeted measures against SARS-CoV-2
FJ Candel, P Barreiro, M Salavert, A Cabello… - Viruses, 2023 - mdpi.com
The clinical evolution of patients infected with the Severe Acute Respiratory Coronavirus
type 2 (SARS-CoV-2) depends on the complex interplay between viral and host factors. The …
type 2 (SARS-CoV-2) depends on the complex interplay between viral and host factors. The …
[HTML][HTML] A Digital Tool for Clinical Evidence–Driven Guideline Development by Studying Properties of Trial Eligible and Ineligible Populations: Development and …
Background Clinical guideline development preferentially relies on evidence from
randomized controlled trials (RCTs). RCTs are gold-standard methods to evaluate the …
randomized controlled trials (RCTs). RCTs are gold-standard methods to evaluate the …
[HTML][HTML] The intertwining of healthcare-associated infections and COVID-19 in Italian intensive care units: An analysis of the SPIN-UTI project from 2006 to 2021
Background Although healthcare-associated infections (HAIs) pose an extraordinary burden
on public health, the impact of coronavirus disease 2019 (COVID-19) is still a matter of …
on public health, the impact of coronavirus disease 2019 (COVID-19) is still a matter of …
A qualitative exploration of barriers to efficient and effective structured medication reviews in primary care: findings from the DynAIRx study
Introduction Structured medication reviews (SMRs), introduced in the United Kingdom (UK)
in 2020, aim to enhance shared decision-making in medication optimisation, particularly for …
in 2020, aim to enhance shared decision-making in medication optimisation, particularly for …
Maternal multimorbidity and preterm birth in Scotland: an observational record-linkage study
Background Multimorbidity is common in women across the life course. Preterm birth is the
single biggest cause of neonatal mortality and morbidity. We aim to estimate the prevalence …
single biggest cause of neonatal mortality and morbidity. We aim to estimate the prevalence …
Trends in COVID-19 hospital outcomes in England before and after vaccine introduction, a cohort study
Widespread vaccination campaigns have changed the landscape for COVID-19, vastly
altering symptoms and reducing morbidity and mortality. We estimate trends in mortality by …
altering symptoms and reducing morbidity and mortality. We estimate trends in mortality by …